OncoFlow:,.

Matan Krasner1, Efrat Barbiro-Michaely1, Ulrike Bening Abu-Shach2

  • 1The Mina & Everard Goodman Faculty of Life Sciences and the Institute for Nanotechnology and Advanced Materials, Bar Ilan University, Ramat-Gan, Israel.

New biotechnology
|March 12, 2025
PubMed
概括

微流体平台OncoFlow评估患者瘤细胞药物反应,以进行个性化非小细胞肺腺癌 (NSCLC) 治疗. 它揭示了NSCLC膜溢出样本中对crizotinib的多种敏感性和对alectinib的耐药性.